• Regulus Therapeutics' (RGLS) "Buy" Rating Reaffirmed at HC Wainwright

    Source: Buzz FX / 15 Mar 2025 08:16:17   America/New_York


    Regulus Therapeutics' (RGLS) "Buy" Rating Reaffirmed at HC Wainwright Written by MarketBeat March 15, 2025 Share Link copied to clipboard. Remove Ads Regulus Therapeutics ( NASDAQ:RGLS - Get Free Report ) 's stock had its "buy" rating reiss
    Read more...
Share on,